GSK’s Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke - TheNote.app

GSK press releases

Follow

GSK’s Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke and severe flare-ups of COPD and asthma, real world study shows

Reduction observed in RSV-related hospitalisations in adults aged ≥60 years

https://www.gsk.com/en-gb/media/press-releases/gsk-s-arexvy-associated-with-reductions-in-certain-rsv-related-risks-including-heart-attack-stroke-and-severe-flare-ups-of-copd-and-asthma-real-world-study-shows/ gsk.com

RSS Hunter • Feb 17